Abstract:The gold standard for treating peripheral nerve injuries that have large nerve gaps where the nerves cannot be directly sutured back together because it creates tension on the nerve, is to incorporate an autologous nerve graft. However, even with the incorporation of a nerve graft, generally patients only regain a small portion of function in limbs affected by the injury. Although, there has been some promising results using growth factors to induce more axon growth through the nerve graft, many of these previous therapies are limited in their ability to release growth factors in a sustained manner and tailor them to a desired time frame. The ideal drug delivery platform would deliver growth factors at therapeutic levels for enough time to grow axons the entire length of the nerve graft. We hypothesized that mineral coated microparticles (MCMs) would bind, stabilize and release biologically active glial cell-derived neurotrophic factor (GDNF) and nerve growth factor (NGF) in a sustained manner. Therefore, the objective of this study was to test the ability of MCMs releasing growth factors at the distal end of a 10 mm sciatic nerve graft, to induce axon growth through the nerve graft and restore hind limb function. After sciatic nerve grafting in Lewis rats, the hind limb function was tested weekly by measuring the angle of the ankle at toe lift-off while walking down a track. Twelve weeks after grafting, the grafts were harvested and myelinated axons were analyzed proximal to the graft, in the center of the graft, and distal to the graft. Under physiological conditions <i>in vitro</i>, the MCMs delivered a burst release of NGF and GDNF for 3 days followed by a sustained release for at least 22 days. <i>In vivo</i>, MCMs releasing NGF and GDNF at the distal end of sciatic nerve grafts resulted in significantly more myelinated axons extending distal to the graft when compared to rats that received nerve grafts without growth factor treatment. The rats with nerve grafts incorporated with MCMs releasing NGF and GDNF also showed significant improvement in hind limb function starting at 7 weeks postoperatively and continuing through 12 weeks postoperatively when compared to rats that received nerve grafts without growth factor treatment. In conclusion, MCMs released biologically active NGF and GDNF in a sustained manner, which significantly enhanced axon growth resulting in a significant improvement of hind limb function in rats. The animal experiments were approved by University of Wisconsin-Madison Animal Care and Use Committee (ACUC, protocol# M5958) on January 3, 2018.

Acceleration of peripheral nerve regeneration following FK506 administration

Promotion of Nerve Regeneration in Peripheral Nerve by Short-Course FK506 after End-to-side Neurorrhaphy.

FK506 contributes to peripheral nerve regeneration by inhibiting neuroinflammatory responses and promoting neuron survival

Changes of Ultrastructure of Regenerative Nerve Fibers in Response to Application of Sustained Releasing Agent FK506

[Effect of FK506 on the Cavernous Nerve Regeneration after Injury].

Nerve Wrap for Local Delivery of FK506/Tacrolimus Accelerates Nerve Regeneration

Ciliary neurotrophic factor for acceleration of peripheral nerve regeneration: an experimental study.

Effect of FK506 in reducing scar formation by inducing fibroblast apoptosis after sciatic nerve injury in rats

A tacrolimus-eluting nerve guidance conduit enhances regeneration in a critical-sized peripheral nerve injury rat model

Effect Of combining FK506 and neurotrophins on neurite branching and elongation

Local FK506 dose‐dependent study using a novel three‐dimensional organotypic assay

Establishment of FK506-Enriched PLGA Nanomaterial Neural Conduit Produced by Electrospinning for the Repair of Long-Distance Peripheral Nerve Injury

A new nerve engineering scaffold with FK506 for bridging large nerve defects

Stem cell, Granulocyte-Colony Stimulating Factor and/or Dihexa to promote limb function recovery in a rat sciatic nerve damage-repair model: Experimental animal studies

Acceleration of peripheral nerve regeneration using nerve conduits in combination with induced pluripotent stem cell technology and a basic fibroblast growth factor drug delivery system

A functional tacrolimus-releasing nerve wrap for enhancing nerve regeneration following surgical nerve repair

Controlled Release of Nerve Growth Factor and Basic Fibroblast Growth Factor Combined with Small-Gap Anastomosis Enhances Sciatic Nerve Regeneration

Functional recovery after peripheral nerve injury via sustained growth factor delivery from mineral-coated microparticles

A novel basic fibroblast growth factor delivery system fabricated with heparin-incorporated fibrin–fibronectin matrices for repairing rat sciatic nerve disruptions

Protection of FK506 Against Neuronal Apoptosis and Axonal Injury Following Experimental Diffuse Axonal Injury.

Delayed Repair of the Peripheral Nerve: A Novel Model in the Rat Sciatic Nerve